00:00Johnson & Johnson beat earnings, then slid 5.75%. Why? That drop came despite a quarter
00:08in which adjusted earnings reached $2.59 per share, and the company raised its adjusted
00:14earnings guidance by $0.06 to $11.10, according to its SEC filing. So why did the stock fall
00:24after stronger guidance? The key contrast was that the upgraded outlook still fell short
00:31of Wall Street's expectations. More on pharmaceuticals, full recap linked.
